Cornerstone Planning Group’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41K Hold
560
﹤0.01% 1273
2026
Q1
$1.76K Hold
560
﹤0.01% 1323
2025
Q4
$1.01K Hold
560
﹤0.01% 1344
2025
Q3
$893 Hold
560
﹤0.01% 1343
2025
Q2
$946 Hold
560
﹤0.01% 1130
2025
Q1
$958 Hold
560
﹤0.01% 1143
2024
Q4
$1.79K Hold
560
﹤0.01% 822
2024
Q3
$1.87K Hold
560
﹤0.01% 785
2024
Q2
$2K Buy
+560
New +$5.45K ﹤0.01% 769

Other funds holding MGNX

Cornerstone Planning Group's MGNX Position: Q2 2026 in Review

Cornerstone Planning Group held its MacroGenics (MGNX) position steady in Q2 2026 at 560 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Cornerstone Planning Group first reported a position in MGNX in Q2 2024 and has held it in 9 quarters since. 34 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Cornerstone Planning Group held 560 shares of MacroGenics worth $2.41K as of Q2 2026.
  • Cornerstone Planning Group left its MacroGenics share count unchanged in Q2 2026.
  • MacroGenics made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1273 holding.
  • Cornerstone Planning Group first reported a position in MacroGenics in Q2 2024 and has held it in 9 quarters since.
  • 34 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.